Microarray analysis of altered gene expression in kidneys of adult spontaneously hypertensive rats

Journal of Applied Research

Volumn 4, Issue 1, 2004, Pages 111-126

  Koo, Ja Ryong ^a   Liang, Kai Hui ^b   Vaziri, Nosratola D ^b  

^a Hallym University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gene expression; Inflammation; Metabolic syndrome; Oxidative stress; SHR

Indexed keywords

CD59 ANTIGEN; GENE PRODUCT; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE; HEME OXYGENASE 3; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE P85 ALPHA; STEAROYL COENZYME A DESATURASE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; DOWN REGULATION; DRUG METABOLISM; ESSENTIAL HYPERTENSION; EXPRESSED SEQUENCE TAG; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; INSULIN RESISTANCE; KIDNEY; LIPID METABOLISM; METABOLIC SYNDROME X; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE;

EID: 6444242332     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Okamoto K, Aorki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J. 1963;27:282-293.
2. Dominiczak AF, Negrin DC, Clark JS, et al. Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies. Hypertension. 2000;35:164-172.
3. Crook ED. The genetics of human hypertension. Semin Nephrol. 2002;22:27-34.
4. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system. NEJM. 1996;334:374-382.
5. Taddei S, Virdis A, Ghiadoni L, et al. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97:2222-2229.
6. Reynisdottir S, Ellerfeldt K, Wahrenberg H, et al. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome. J Clin Invest. 1994;93:2590-2599.
7. Aitman TJ, Glazier AM, Wallace CA, et al. Identification of Cd36 (Fat) as an insulin resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genet. 1999;21:76-83.
8. Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension. 2000;36:957-964.
9. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. NEJM. 2002;346:913-923.
10. Rocke DM, Lorenzato S. A two-component model for measurement error in analytical chemistry. Technometrics. 1995;37:176-184.
11. Yu Z, Xu F, Huse LM, et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res. 2000;87:992-998.
12. Hamet P, Malo D, Hashimoto T, Tremblay J. Heat stress genes in hypertension. J Hypenens. 1990;8(Suppl):S47-52.
13. Iwai N, Inagami T. Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension. 1991;17:161-169.
14. Iwai N, Katsuya T, Mannami T, et al. Association between SAH, an acyl-coA synthetase gene, and hypertriglyceridemia, obesity, and hypertension. Circulation. 2002;105:41-47.
15. Maier KG, Roman RJ. Cytochrome P450 metabolites of arachidonic acid in the control of renal function. Curr Opin Nephrol Hypertens. 2001;10:81-87.
16. Kim YC, Ntambi JM. Regulation of stearoyl-CoA desaturase genes: role in cellular metabolism and preadipocyte differentiation. Biochem Biophys Res Commun. 2001;266:1-4.
17. Ntambi JM. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res. 1999;40:1549-1558.
18. Bassilian S, Ahmed S, Lim SK, et al. Loss of regulation of lipogenesis in the Zucker diabetic rat. II. Changes in stearate and oleate synthesis. Am J Physiol Endocrinol Metab. 2002;282:E507-E513.
19. Jones BH, Maher MA, Banz WJ, et al. Adipose tissue stearoyl-CoA desaturase mRNA is increased by obesity and decreased by polyunsaturated fatty acids. Am J Physiol Endocrinol Metab. 1996;270:E44-E49.
20. Nakaya Y, Minami A, Harada N, et al. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr. 2000;71:54-58.
21. Anuradha CV, Balakrishnan SD. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol. 1999;77:749-754.
22. Burant CF, Takeda J, Bell GI, Davidson NO. Fructose transporter in human spermatozoa and small intestine is GLUTS. J Biol Chem. 1992;267:14523-14526.
23. Miatello RM, Damiani MT, Nolly HL. Cardiovascular kinin-generating capability in hypertensive fructose-fed rats. J Hypertens. 1998;16:1273-1277.
24. Argaud D, Zhang Q, Pan W, et al. Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states. Diabetes. 1996;45:1563-1571.
25. Lochhead PA, Coghlan M, Rice SQ, Sutherland C. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes. 2001;50:937-946.
26. Kowluru A. Adenine and guanine nucleotide-specific succinyl-CoA synthetases in the clonal beta-cell mitochondria: implications in the beta-cell high-energy phosphate metabolism in relation to physiological insulin secretion. Diabetologia. 2001 ;44:89-94.
27. Whitehead JP, Clark SF, Urso B, James DE. Signaling through the insulin receptor. Curr Opin Cell Biol. 2000;12:222-228.
28. Allan BB, Moyer BD, Balch WE. Rab. 1 recruitment of pi 15 into a cis-SNARE complex: programming budding COPII vesicles for fusion. Science. 2000;289:444-448.
29. Narasimhan S. Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide b 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in b-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J Biol Chem. 1982;257:10235-10242.
30. Ing BL, Chen H, Robinson KA, et al. Characterization of a mutant GLUT4 lacking the N-glycosylation site: studies in transfected rat adipose cells. Biochem Biophys Res Commun. 1996;218:76-82.
31. Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet. 1999;354:2048-2049.
32. Higashi Y, Sasaki S, Nakagawa K, et al. Endothelial function and oxidative stress in renovascular hypertension. NEJM. 2002;346:1954-1962.
33. Swei A, Lacy F, DeLano FA, Schmid-Schonbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension 1997;30:1628-1633.
34. Vaziri ND, Oveisi F, Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int. 1998;53:1748-1754.
35. Lu SC. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J. 1999;13:1169-1183.
36. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S- transferase family of enzymes. Mutat Res. 2001;482:21-26.
37. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes hypertension in normal rats. Hypertension. 2000;36:142-146.
38. Agarwal A, Nick HS. Renal response to tissue injury: Lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol. 2000;11:965-973.
39. Motterlini R, Clark JE, Foresti R, et al. Carbon monoxide-releasing molecules: Characterization of biochemical and vascular activities. Circ Res. 2002;90:e17-e24.
40. Lohr JW, Willsky GR, Acara MA. Renal drug metabolism. Pharmacol Rev I998;57:107-141.
41. Yoshizumi M, Ishimura Y, Masuda Y, et al. Physiological significance of plasma sulfoconjugated dopamine: experimental and clinical studies. Hypertens Res. 1995;18(Suppl 1):S101-106.
42. Harriet P. Environmental stress and genes of hypertension. Clin Exp Pharmacol Physiol. 1995;22:S394-S398.
43. Xu Q, Li DG, Holbrook NJ, Udelsman R. Acute hypertension induces heat-shock protein 70 gene expression in rat aorta. Circulation. 1995;92:1223-1229.
44. Kiang JG, Tsokos GC. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther. 1998;80:183-201.
45. Davis SR, Cousins RJ. Metallothionein expression in animals: a physiological perspective on function. J Nutr. 2000;130:1085-1088.
46. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J. 1988;256:251-255.
47. Acosta J, Hettinga J, Fluckiger R, et al. Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci USA. 2000;97: 5450-5455,.
48. Torzewski J, Oldroyd R, Lachmann P. Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol. 1996;16:673-677.
49. Nava M, Quiroz Y, Vaziri ND, Rodriguez-Iturbe B. Melatonin reduces renal interstitial infiltration and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol. 2003;284:447-454.
50. Kazazian HH Jr. Mobile elements and disease. Curr Opin Genet Dev. 1998;8:343-350.
51. Lodish H, Berk A, Zipursky SL, et al. Molecular structure of genes and chromosomes. In: Molecular Cell Biology, 4th ed. New York, NY: W. H. Freeman; 2000:294-340.
52. Glazier AM, Scott J, Aitman TJ. Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mamm Genome. 2002;13:108-113.
53. Gotoda T, Iizuka Y, Kato N, et al. Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat Genet. 1999;22:226-228.